journal article·2023-04Open access

Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis

David A. McBride, Matthew D. Kerr, Wade T. Johnson, Anders Nguyen, Martina Zoccheddu, Mina Yao, Edward B. Prideaux, Nicholas C. Dorn, Wei Wang, Mattias N.D. Svensson, Nunzio Bottini, Nisarg J. Shah

Advanced Science· Volume 10· Issue 11

Abstract

Abstract Disease modifying antirheumatic drugs (DMARDs) have improved the prognosis of autoimmune inflammatory arthritides but a large fraction of patients display partial or nonresponsiveness to front‐line DMARDs. Here, an immunoregulatory approach based on sustained joint‐localized release of all‐trans retinoic acid (ATRA), which modulates local immune activation and enhances disease‐protective T cells and leads to systemic disease control is reported. ATRA imprints a unique chromatin landscape in T cells, which is associated with an enhancement in the differentiation of naïve T cells into anti‐inflammatory regulatory T cells (Treg) and suppression of Treg destabilization. Sustained release poly‐(lactic‐co‐glycolic) acid (PLGA)‐based biodegradable microparticles encapsulating ATRA (PLGA‐ATRA MP) are retained in arthritic mouse joints after intra‐articular (IA) injection. IA PLGA‐ATRA MP enhance migratory Treg which in turn reduce inflammation and modify disease in injected and uninjected joints, a phenotype that is also reproduced by IA injection of Treg. PLGA‐ATRA MP reduce proteoglycan loss and bone erosions in the SKG and collagen‐induced arthritis mouse models of autoimmune arthritis. Strikingly, systemic disease modulation by PLGA‐ATRA MP is not associated with generalized immune suppression. PLGA‐ATRA MP have the potential to be developed as a disease modifying agent for autoimmune arthritis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Autoimmune and Inflammatory Disorders Research · Immunotherapy and Immune Responses · Systemic Lupus Erythematosus Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nanoengineering University of California La Jolla San Diego CA 92093 USA

Chemical Engineering Program University of California La Jolla San Diego CA 92093 USA

Department of Rheumatology and Inflammation Research Sahlgrenska Academy Institute of Medicine University of Gothenburg Gothenburg 41346 Sweden

Department of Medicine Division of Rheumatology Allergy and Immunology University of California La Jolla San Diego CA 92093 USA

Department of Chemistry and Biochemistry University of California La Jolla San Diego CA 92093 USA

Department of Cellular and Molecular Medicine University of California La Jolla San Diego CA 92093 USA

Funding

National Institutes of Health · National Science Foundation

References (97)

Show source-provided references
1. 10.1007/s00296-015-3415-x10.1007/s00296-015-3415-x ↗
2. 10.1001/jama.2018.1310310.1001/jama.2018.13103 ↗
3. 10.1038/nrrheum.2014.21210.1038/nrrheum.2014.212 ↗
4. 10.1086/58706310.1086/587063 ↗
5. 10.1186/s13075-015-0590-910.1186/s13075-015-0590-9 ↗
6. 10.1136/annrheumdis-2012-20152610.1136/annrheumdis-2012-201526 ↗
7. 10.1038/s41467-017-02659-x10.1038/s41467-017-02659-x ↗
8. 10.1038/ncomms1184910.1038/ncomms11849 ↗
9. 10.1056/NEJMoa200411410.1056/NEJMoa2004114 ↗
10. 10.1002/art.4057810.1002/art.40578 ↗
11. 10.1038/nrrheum.2015.15710.1038/nrrheum.2015.157 ↗
12. 10.1038/nm.205010.1038/nm.2050 ↗
13. 10.1186/ar233310.1186/ar2333 ↗
14. 10.1016/j.jaut.2012.05.02110.1016/j.jaut.2012.05.021 ↗
15. Cope A. P. · Clin. Exp. Rheumatol. · 2007 · 25 · S4
16. 10.3389/fimmu.2015.0038410.3389/fimmu.2015.00384 ↗
17. 10.1136/ard.50.11.79210.1136/ard.50.11.792 ↗
18. 10.1111/j.1742-4658.2008.06580.x10.1111/j.1742-4658.2008.06580.x ↗
19. 10.1002/eji.20104039110.1002/eji.201040391 ↗
20. 10.1016/j.cyto.2015.07.00510.1016/j.cyto.2015.07.005 ↗
21. 10.1016/j.autrev.2013.12.00410.1016/j.autrev.2013.12.004 ↗
22. 10.1172/JCI12326710.1172/JCI123267 ↗
23. 10.1038/ni.240210.1038/ni.2402 ↗
24. 10.1084/jem.2009215310.1084/jem.20092153 ↗
25. 10.1038/ni.166310.1038/ni.1663 ↗
26. 10.1038/nature0811410.1038/nature08114 ↗
27. 10.1016/j.cell.2012.09.01610.1016/j.cell.2012.09.016 ↗
28. 10.1038/nature0481510.1038/nature04815 ↗
29. 10.1073/pnas.040186610110.1073/pnas.0401866101 ↗
30. 10.1111/ajt.1493610.1111/ajt.14936 ↗
31. 10.1038/mi.2017.1710.1038/mi.2017.17 ↗
32. 10.1371/journal.pone.001735910.1371/journal.pone.0017359 ↗
33. 10.1111/imm.1239310.1111/imm.12393 ↗
34. 10.1124/jpet.117.24052310.1124/jpet.117.240523 ↗
35. 10.1002/jor.2419110.1002/jor.24191 ↗
36. 10.1186/ar81110.1186/ar811 ↗
37. 10.1038/nature0211910.1038/nature02119 ↗
38. 10.1038/ncprheum097310.1038/ncprheum0973 ↗
39. 10.1136/annrheumdis-2020-21924710.1136/annrheumdis-2020-219247 ↗
40. 10.1084/jem.2009230110.1084/jem.20092301 ↗
41. 10.1172/jci.insight.14186810.1172/jci.insight.141868 ↗
42. 10.1189/jlb.010900610.1189/jlb.0109006 ↗
43. 10.4049/jimmunol.181.4.227710.4049/jimmunol.181.4.2277 ↗
44. 10.1126/science.114569710.1126/science.1145697 ↗
45. Bird H. · 2013
46. 10.1292/jvms.71.71310.1292/jvms.71.713 ↗
47. 10.1007/3-7643-7419-5_1110.1007/3-7643-7419-5_11 ↗
48. 10.1172/jci.insight.13250810.1172/jci.insight.132508 ↗
49. 10.1038/cmi.2014.13310.1038/cmi.2014.133 ↗
50. 10.1038/s41584-021-00585-310.1038/s41584-021-00585-3 ↗
51. 10.1111/imm.1303710.1111/imm.13037 ↗
52. 10.1371/journal.pone.002459010.1371/journal.pone.0024590 ↗
53. 10.4049/jimmunol.110270610.4049/jimmunol.1102706 ↗
54. 10.1182/blood-2007-06-09643810.1182/blood-2007-06-096438 ↗
55. 10.1016/j.clim.2005.11.01210.1016/j.clim.2005.11.012 ↗
56. 10.1016/j.immuni.2008.09.01810.1016/j.immuni.2008.09.018 ↗
57. 10.1038/nature0875010.1038/nature08750 ↗
58. 10.1016/j.cell.2014.07.03110.1016/j.cell.2014.07.031 ↗
59. 10.1073/pnas.140878011110.1073/pnas.1408780111 ↗
60. 10.1111/cei.1325610.1111/cei.13256 ↗
61. 10.1111/j.1600-065X.2007.00551.x10.1111/j.1600-065X.2007.00551.x ↗
62. 10.1038/3258810.1038/32588 ↗
63. 10.4049/jimmunol.167.2.107210.4049/jimmunol.167.2.1072 ↗
64. 10.1111/j.1749-6632.2003.tb06042.x10.1111/j.1749-6632.2003.tb06042.x ↗
65. 10.3389/fimmu.2017.0156010.3389/fimmu.2017.01560 ↗
66. 10.3892/mmr.2021.1250810.3892/mmr.2021.12508 ↗
67. 10.1146/annurev.immunol.26.021607.09025410.1146/annurev.immunol.26.021607.090254 ↗
68. 10.4049/jimmunol.200.Supp.176.1710.4049/jimmunol.200.Supp.176.17 ↗
69. 10.1126/scitranslmed.aaa930110.1126/scitranslmed.aaa9301 ↗
70. 10.1021/acsabm.9b0009210.1021/acsabm.9b00092 ↗
71. 10.1186/ar461310.1186/ar4613 ↗
72. 10.1002/art.4158510.1002/art.41585 ↗
73. 10.1002/art.1019810.1002/art.10198 ↗
74. 10.1371/journal.pone.023939610.1371/journal.pone.0239396 ↗
75. 10.1016/j.jconrel.2012.01.01310.1016/j.jconrel.2012.01.013 ↗
76. 10.1016/j.joca.2017.02.28810.1016/j.joca.2017.02.288 ↗
77. 10.1172/JCI20042179510.1172/JCI200421795 ↗
78. 10.1126/sciadv.abb060610.1126/sciadv.abb0606 ↗
79. 10.1167/iovs.12-1143210.1167/iovs.12-11432 ↗
80. 10.3109/08820139.2013.82526910.3109/08820139.2013.825269 ↗
81. 10.1096/fj.202001734R10.1096/fj.202001734R ↗
82. 10.1016/0300-483X(84)90122-710.1016/0300-483X(84)90122-7 ↗
83. 10.1002/ddr.1028310.1002/ddr.10283 ↗
84. 10.1002/eji.20204868110.1002/eji.202048681 ↗
85. 10.1186/ar312010.1186/ar3120 ↗
86. 10.3389/fimmu.2022.74648410.3389/fimmu.2022.746484 ↗
87. 10.1038/nm.343210.1038/nm.3432 ↗
88. 10.1038/nmeth.192310.1038/nmeth.1923 ↗
89. 10.1038/s41598-019-45839-z10.1038/s41598-019-45839-z ↗
90. 10.1093/bioinformatics/btp35210.1093/bioinformatics/btp352 ↗
91. 10.1093/nar/gkw25710.1093/nar/gkw257 ↗
92. 10.1186/gb-2008-9-9-r13710.1186/gb-2008-9-9-r137 ↗
93. 10.1093/bioinformatics/btq03310.1093/bioinformatics/btq033 ↗
94. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
95. 10.1016/j.molcel.2010.05.00410.1016/j.molcel.2010.05.004 ↗
96. Kanneganti K. · Chem. Eng. Educ. · 2011 · 45 · 101
97. 10.1189/jlb.3A0714-317R10.1189/jlb.3A0714-317R ↗